PL80303B1 - - Google Patents
Download PDFInfo
- Publication number
- PL80303B1 PL80303B1 PL1969135883A PL13588369A PL80303B1 PL 80303 B1 PL80303 B1 PL 80303B1 PL 1969135883 A PL1969135883 A PL 1969135883A PL 13588369 A PL13588369 A PL 13588369A PL 80303 B1 PL80303 B1 PL 80303B1
- Authority
- PL
- Poland
- Prior art keywords
- poly
- vaccine
- influenza
- molecular weight
- virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76100468A | 1968-09-19 | 1968-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL80303B1 true PL80303B1 (xx) | 1975-08-30 |
Family
ID=25060824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1969135883A PL80303B1 (xx) | 1968-09-19 | 1969-09-18 |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS502009B1 (xx) |
| AT (1) | AT296500B (xx) |
| BE (1) | BE739046A (xx) |
| BR (1) | BR6912481D0 (xx) |
| CA (1) | CA918072A (xx) |
| CS (1) | CS160110B2 (xx) |
| DE (1) | DE1946319A1 (xx) |
| DK (1) | DK128503B (xx) |
| ES (1) | ES371557A1 (xx) |
| FI (1) | FI46863C (xx) |
| FR (1) | FR2018431B1 (xx) |
| GB (1) | GB1234718A (xx) |
| IE (1) | IE33578B1 (xx) |
| IL (1) | IL32962A (xx) |
| NL (1) | NL167324C (xx) |
| PL (1) | PL80303B1 (xx) |
| SE (1) | SE364987B (xx) |
| ZA (1) | ZA695759B (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8301996A (nl) * | 1983-06-06 | 1985-01-02 | Duphar Int Res | Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins. |
| ATE292980T1 (de) | 1996-10-11 | 2005-04-15 | Univ California | Immunostimulierende oligonucleotidekonjugate |
-
1969
- 1969-08-12 ZA ZA695759A patent/ZA695759B/xx unknown
- 1969-09-01 NL NL6913336.A patent/NL167324C/xx not_active IP Right Cessation
- 1969-09-08 IL IL32962A patent/IL32962A/xx unknown
- 1969-09-09 FI FI692588A patent/FI46863C/fi active
- 1969-09-09 IE IE1263/69A patent/IE33578B1/xx unknown
- 1969-09-12 DE DE19691946319 patent/DE1946319A1/de active Pending
- 1969-09-15 SE SE12648/69A patent/SE364987B/xx unknown
- 1969-09-15 GB GB45333/69A patent/GB1234718A/en not_active Expired
- 1969-09-15 ES ES371557A patent/ES371557A1/es not_active Expired
- 1969-09-16 BR BR212481/69A patent/BR6912481D0/pt unknown
- 1969-09-16 CA CA062152A patent/CA918072A/en not_active Expired
- 1969-09-17 CS CS6319A patent/CS160110B2/cs unknown
- 1969-09-18 FR FR696931843A patent/FR2018431B1/fr not_active Expired
- 1969-09-18 PL PL1969135883A patent/PL80303B1/pl unknown
- 1969-09-18 BE BE739046D patent/BE739046A/xx unknown
- 1969-09-18 DK DK497969AA patent/DK128503B/da unknown
- 1969-09-19 AT AT892669A patent/AT296500B/de not_active IP Right Cessation
- 1969-09-19 JP JP44074057A patent/JPS502009B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NL167324B (nl) | 1981-07-16 |
| BR6912481D0 (pt) | 1973-02-08 |
| FR2018431A1 (xx) | 1970-05-29 |
| BE739046A (xx) | 1970-03-18 |
| GB1234718A (en) | 1971-06-09 |
| ES371557A1 (es) | 1972-03-16 |
| CS160110B2 (xx) | 1975-02-28 |
| JPS502009B1 (xx) | 1975-01-23 |
| SE364987B (xx) | 1974-03-11 |
| FR2018431B1 (xx) | 1973-06-08 |
| FI46863B (xx) | 1973-04-02 |
| NL6913336A (xx) | 1970-03-23 |
| ZA695759B (en) | 1971-03-31 |
| NL167324C (nl) | 1981-12-16 |
| IL32962A (en) | 1973-01-30 |
| DK128503B (da) | 1974-05-13 |
| DE1946319A1 (de) | 1970-03-26 |
| IE33578B1 (en) | 1974-08-21 |
| FI46863C (fi) | 1973-07-10 |
| AT296500B (de) | 1972-02-10 |
| IE33578L (en) | 1970-03-19 |
| CA918072A (en) | 1973-01-02 |
| SU441711A3 (ru) | 1974-08-30 |
| IL32962A0 (en) | 1969-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3906092A (en) | Stimulation of antibody response | |
| US5679356A (en) | Use of GM-CSF as a vaccine adjuvant | |
| Beran | Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients | |
| DE60023300T2 (de) | Verwendung von cpg als adjuvans für hivimpstoff | |
| JP2018510874A (ja) | アジュバント組成物及び関連する方法 | |
| CA2632516C (en) | Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants | |
| KR20080016592A (ko) | 폴리이노신산-폴리시티딜산-기초 보조제 | |
| JP2001526688A (ja) | オリゴヌクレオチドアジュバント | |
| CA2327389C (en) | Dna vaccine for horses containing as at least one adjuvant, polymers of acrylic or methacrylic acid, or copolymers of maleic anhydride and ethylene | |
| CN109701010B (zh) | 疫苗复合佐剂系统及其在抗原中的应用 | |
| Hilleman | Double-stranded RNAs (poly I: C) in the prevention of viral infections | |
| JP2023506440A (ja) | 免疫刺激性組成物及びその用途 | |
| EP4332225A1 (en) | Application of artificially synthesized cpg single-stranded deoxyoligonucleotide in vaccines | |
| DiStefano et al. | Immunogenicity of a reduced-dose whole killed rabies vaccine is significantly enhanced by ISCOMATRIX™ adjuvant, Merck amorphous aluminum hydroxylphosphate sulfate (MAA) or a synthetic TLR9 agonist in rhesus macaques | |
| Gazdar et al. | Interferon inducers: enhancement of viral oncogenesis in mice and rats | |
| PL80303B1 (xx) | ||
| WO2002058726A1 (en) | Method for treating an hiv-infected individual by combining immunization with structured interruption of anti-retroviral treatment | |
| Worthington et al. | Effectiveness of an interferon stimulator in immunosuppressed mice | |
| DE69929432T2 (de) | Erhöhung der immunantworten bei genetischer immunisierung durch verwendung eines chemokins | |
| JP3072489B2 (ja) | 免疫刺激効果を誘出する製薬組成物 | |
| CN113967252B (zh) | 一种禽用免疫增强剂、含有免疫增强剂的疫苗组合物及其应用 | |
| CN106163554B (zh) | 一种包含pika佐剂的狂犬病组合物 | |
| Billiau et al. | Adjuvant activity of polyacetal carboxylate for antibody induction in mice and guinea pigs | |
| Tsalik | DNA-based immunotherapy to treat atopic disease | |
| CN109701011B (zh) | 疫苗复合佐剂系统及其在抗原中的应用 |